These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Avcin T, Silverman ED. Lupus; 2007 Oct; 16(8):627-33. PubMed ID: 17711899 [Abstract] [Full Text] [Related]
43. [Antiphospholipid syndrome and kidney]. Roccatello D, Rossi D, Giachino O, Bazzan M, Mazzucco G. G Ital Nefrol; 2007 Oct; 24(2):111-20. PubMed ID: 17458826 [Abstract] [Full Text] [Related]
44. Cardiac manifestations in antiphospholipid syndrome. Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384 [Abstract] [Full Text] [Related]
45. Understanding the antiphospholipid syndrome and its treatment. Arnout J, Jankowski M. Curr Hematol Rep; 2005 Sep; 4(5):385-90. PubMed ID: 16131440 [Abstract] [Full Text] [Related]
46. Renal infarction in a severely hypertensive patient with lupus erythematosus and antiphospholipid antibodies. Hernández D, Dominguez ML, Diaz F, Fernandez ML, Lorenzo V, Rodriguez A, Torres A. Nephron; 1996 Sep; 72(2):298-301. PubMed ID: 8684543 [Abstract] [Full Text] [Related]
47. The Italian Registry of Antiphospholipid Antibodies. Finazzi G. Haematologica; 1997 Sep; 82(1):101-5. PubMed ID: 9107095 [Abstract] [Full Text] [Related]
48. Arterial stenosis in antiphospholipid syndrome: Update on the unrevealed mechanisms of an endothelial disease. Harifi G, Nour-Eldine W, Noureldine MHA, Berjaoui MB, Kallas R, Khoury R, Uthman I, Al-Saleh J, Khamashta MA. Autoimmun Rev; 2018 Mar; 17(3):256-266. PubMed ID: 29339317 [Abstract] [Full Text] [Related]
49. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM, Patrushev LI, Stukacheva EA, Miroshnikov AI, Tikhonova TL, Nasonov EL, Alekberova ZS. Ter Arkh; 2000 Mar; 72(5):34-8. PubMed ID: 11109617 [Abstract] [Full Text] [Related]
50. Vasculitis in antiphospholipid syndrome. Lally L, Sammaritano LR. Rheum Dis Clin North Am; 2015 Mar; 41(1):109-23, ix. PubMed ID: 25399943 [Abstract] [Full Text] [Related]
53. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss. Cohen D, Buurma A, Goemaere NN, Girardi G, le Cessie S, Scherjon S, Bloemenkamp KW, de Heer E, Bruijn JA, Bajema IM. J Pathol; 2011 Dec; 225(4):502-11. PubMed ID: 21688269 [Abstract] [Full Text] [Related]
55. Thrombosis of the terminal aorta, deep vein thrombosis, recurrent fetal loss, and antiphospholipid antibodies. Case report. Hohlfeld J, Schneider M, Hein R, Barthels M, von der Lieth H, Rosenthal H, Lang W, Alexander K. Vasa; 1996 Mar; 25(2):194-9. PubMed ID: 8659225 [Abstract] [Full Text] [Related]
56. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis. Cacoub P, Wechsler B, Piette JC, Beaufils H, Herreman G, Bletry O, Godeau P. Clin Exp Rheumatol; 1993 Mar; 11(5):479-85. PubMed ID: 8275582 [Abstract] [Full Text] [Related]
57. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. Nochy D, Daugas E, Droz D, Beaufils H, Grünfeld JP, Piette JC, Bariety J, Hill G. J Am Soc Nephrol; 1999 Mar; 10(3):507-18. PubMed ID: 10073601 [Abstract] [Full Text] [Related]
59. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays. Alarcon-Segovia D, Mestanza M, Cabiedes J, Cabral AR. J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149 [Abstract] [Full Text] [Related]